AC Immune SA (ACIU)
2.33
-0.02
(-0.85%)
USD |
NASDAQ |
May 10, 16:00
2.33
0.00 (0.00%)
After-Hours: 18:04
AC Immune 1 Year Total Returns (Daily): 11.90% for May 9, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 09, 2024 | 11.90% |
| May 08, 2024 | 11.37% |
| May 07, 2024 | 14.15% |
| May 06, 2024 | 15.11% |
| May 03, 2024 | 29.19% |
| May 02, 2024 | 29.79% |
| May 01, 2024 | 25.63% |
| April 30, 2024 | 27.84% |
| April 29, 2024 | 23.71% |
| April 26, 2024 | 15.20% |
| April 25, 2024 | 19.27% |
| April 24, 2024 | 13.40% |
| April 23, 2024 | 9.17% |
| April 22, 2024 | 11.01% |
| April 19, 2024 | 9.77% |
| April 18, 2024 | 7.94% |
| April 17, 2024 | 10.00% |
| April 16, 2024 | 9.38% |
| April 15, 2024 | 12.50% |
| April 12, 2024 | 25.11% |
| April 11, 2024 | 26.98% |
| April 10, 2024 | 30.23% |
| April 09, 2024 | 24.44% |
| April 08, 2024 | 24.44% |
| April 05, 2024 | 22.22% |
| Date | Value |
|---|---|
| April 04, 2024 | 23.04% |
| April 03, 2024 | 23.89% |
| April 02, 2024 | 15.38% |
| April 01, 2024 | 16.67% |
| March 28, 2024 | 28.14% |
| March 27, 2024 | 35.87% |
| March 26, 2024 | 27.93% |
| March 25, 2024 | 30.63% |
| March 22, 2024 | 43.46% |
| March 21, 2024 | 43.18% |
| March 20, 2024 | 50.69% |
| March 19, 2024 | 51.35% |
| March 18, 2024 | 57.66% |
| March 15, 2024 | 52.17% |
| March 14, 2024 | 44.78% |
| March 13, 2024 | 68.95% |
| March 12, 2024 | 56.25% |
| March 11, 2024 | 52.68% |
| March 08, 2024 | 57.50% |
| March 07, 2024 | 60.33% |
| March 06, 2024 | 62.34% |
| March 05, 2024 | 64.58% |
| March 04, 2024 | 51.67% |
| March 01, 2024 | 61.09% |
| February 29, 2024 | 58.08% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-68.29%
Minimum
Jun 16 2022
185.6%
Maximum
Dec 27 2023
-8.86%
Average
-14.77%
Median
Jul 31 2023
1 Year Total Returns (Daily) Benchmarks
| CRISPR Therapeutics AG | -15.48% |
| Addex Therapeutics Ltd | -40.06% |
| NLS Pharmaceutics Ltd | -88.68% |
| Molecular Partners AG | -41.72% |
| MoonLake Immunotherapeutics | 52.84% |